755 related articles for article (PubMed ID: 18937654)
21. Cancer incidence and survival in kidney transplant patients.
Navarro MD; López-Andréu M; Rodríguez-Benot A; Agüera ML; Del Castillo D; Aljama P
Transplant Proc; 2008 Nov; 40(9):2936-40. PubMed ID: 19010153
[TBL] [Abstract][Full Text] [Related]
22. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience.
Veness MJ; Quinn DI; Ong CS; Keogh AM; Macdonald PS; Cooper SG; Morgan GW
Cancer; 1999 Apr; 85(8):1758-64. PubMed ID: 10223570
[TBL] [Abstract][Full Text] [Related]
23. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
Chakravarty EF; Michaud K; Wolfe F
J Rheumatol; 2005 Nov; 32(11):2130-5. PubMed ID: 16265690
[TBL] [Abstract][Full Text] [Related]
24. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma.
Euvrard S; Kanitakis J; Decullier E; Butnaru AC; Lefrançois N; Boissonnat P; Sebbag L; Garnier JL; Pouteil-Noble C; Cahen R; Morelon E; Touraine JL; Claudy A; Chapuis F
Transplantation; 2006 Apr; 81(8):1093-100. PubMed ID: 16641592
[TBL] [Abstract][Full Text] [Related]
25. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
26. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
Lewis KG; Weinstock MA
Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
[TBL] [Abstract][Full Text] [Related]
27. Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers.
Veness MJ; Harris D
Australas Radiol; 2007 Feb; 51(1):12-20. PubMed ID: 17217484
[TBL] [Abstract][Full Text] [Related]
28. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
29. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
[TBL] [Abstract][Full Text] [Related]
30. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010.
Mudigonda T; Levender MM; O'Neill JL; West CE; Pearce DJ; Feldman SR
Dermatol Surg; 2013 Mar; 39(3 Pt 1):345-64. PubMed ID: 23190408
[TBL] [Abstract][Full Text] [Related]
31. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
[TBL] [Abstract][Full Text] [Related]
32. Predicting risk of nonmelanoma skin cancer and premalignant skin lesions in renal transplant recipients.
Urwin HR; Jones PW; Harden PN; Ramsay HM; Hawley CM; Nicol DL; Fryer AA
Transplantation; 2009 Jun; 87(11):1667-71. PubMed ID: 19502958
[TBL] [Abstract][Full Text] [Related]
33. Melanomas in renal transplant recipients.
Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
[TBL] [Abstract][Full Text] [Related]
34. Squamous and basal cell carcinoma in heart transplant recipients.
Lampros TD; Cobanoglu A; Parker F; Ratkovec R; Norman DJ; Hershberger R
J Heart Lung Transplant; 1998 Jun; 17(6):586-91. PubMed ID: 9662094
[TBL] [Abstract][Full Text] [Related]
35. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
[TBL] [Abstract][Full Text] [Related]
36. Influence of induction therapy on rejection and survival in heart transplantation.
Almenar L; García-Palomar C; Martínez-Dolz L; Chamorro C; Moro J; Zorio E; Arnau MA; Rueda J; Osa A; Cardo ML
Transplant Proc; 2005 Nov; 37(9):4024-7. PubMed ID: 16386616
[TBL] [Abstract][Full Text] [Related]
37. Malignancy after kidney transplantation: results of 400 patients from a single center.
Stratta P; Morellini V; Musetti C; Turello E; Palmieri D; Lazzarich E; Cena T; Magnani C
Clin Transplant; 2008; 22(4):424-7. PubMed ID: 18312442
[TBL] [Abstract][Full Text] [Related]
38. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management.
Tessari G; Girolomoni G
Dermatol Surg; 2012 Oct; 38(10):1622-30. PubMed ID: 22805312
[TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients.
Sommerer C; Hartschuh W; Enk A; Meuer S; Zeier M; Giese T
Clin Transplant; 2008; 22(5):549-54. PubMed ID: 18394001
[TBL] [Abstract][Full Text] [Related]
40. Low incidence of malignancy after transplantation in Chinese heart allograft recipients.
Hsu RB; Chen RJ; Chou NK; Ko WJ; Wang SS; Chu SH
Transpl Int; 2005 Mar; 18(3):283-8. PubMed ID: 15730487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
